The French regulatory system facing the development of antitumor immunotherapy: Issues related to patient access to new therapies according to the French society of ImmunoTherapy against Cancer (FITC)

xlomafota13 shared this article with you from Inoreader The French regulatory system facing the development of antitumor immunotherapy: Issues related to patient access to new therapies according to the French society of ImmunoTherapy against Cancer (FITC) Via Association française pour l'étude du cancer Bull Cancer. 2021 Mar 11:S0007-4551(21)00067-9. doi: 10.1016/j.bulcan.2020.12.008. Online ahead of print. NO ABSTRACT PMID:33715847 | DOI:10.1016/j.bulcan.2020.12.008 View on the web Inoreader. Take back control of your news feed. Follow us on Twitter and Facebook.